Andreu Vaquer

Mr. Andreu Vaquer


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2021 in The Analyst
Verified
Journal Article
Open access
PDF file
AVAndreu Vaquer
Andreu Vaquer
EBEnrique Barón
Enrique Barón
RRRoberto De La Rica
Roberto De La Rica
Colorimetric wearable biosensors made of paper detect glucose in sweat using a smartphone as reader. Measurements correlated well with blood glucose levels, these devices could be used as “over-the-counter” tests for monitoring glucose.

20 February 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
FBFrancisco Manuel Moyano Bouzada
Francisco Manuel Moyano Bouzada
BCBartomeu Mestre Cañas
Bartomeu Mestre Cañas
AVAndreu Vaquer
Andreu Vaquer
STSofia Tejada
Sofia Tejada
RRRoberto De La Rica
Roberto De La Rica
Lower respiratory tract infections (LRTIs) are a leading cause of mortality worldwide, claiming millions of lives each year and imposing significant healthcare costs. Accurate detection of respiratory pathogens is essential for the effective management of LRTIs. However, this process often relies on sputum analysis, which requires extensive pretreatment steps. The viscous nature and complex composition of sputum present additional challenges, especially in settings where a rapid diagnosis at the point of care is essential. In this review, we describe the main types of LRTI, highlighting different patient care pathway and points of care. We review current methods for liquefying sputum samples and provide an overview of current commercially available diagnostic tools used in hospitals for LRTI detection. Furthermore, we critically review recent advancements in the literature focused on detecting respiratory pathogens and mechanisms of antimicrobial resistance in sputum, including nucleic acid amplification tests, immunoassays and other innovative approaches. Throughout the paper, we highlight challenges and opportunities associated with developing new biosensor technologies tailored for detecting respiratory pathogens in lower respiratory specimens. By shedding light on these pressing issues, we aim to inspire scientific community to create innovative diagnostic tools to address the urgent healthcare burden of lung diseases.

27 February 2022 in Sensors
Verified
Journal Article
Open access
PDF file
SRSteven M. Russell
Steven M. Russell
AAAlejandra Alba-Patiño
Alejandra Alba-Patiño
AVAndreu Vaquer
Andreu Vaquer
ACAntonio Clemente
Antonio Clemente
RRRoberto De La Rica
Roberto De La Rica
Measuring the colorimetric signals produced by the biospecific accumulation of colorimetric probes and recording the results is a key feature for next-generation paper-based rapid tests. Manual processing of these tests is time-consuming and prone to a loss of accuracy when interpreting faint and patchy signals. Proprietary, closed-source readers and software companies offering automated smartphone-based assay readings have both been criticized for interoperability issues. Here, we introduce a minimal reader prototype composed of open-source hardware and open-source software that has the benefits of automatic assay quantification while avoiding the interoperability issues associated with closed-source readers. An image-processing algorithm was developed to automate the selection of an optimal region of interest and measure the average pixel intensity. When used to quantify signals produced by lateral flow immunoassays for detecting antibodies against SARS-CoV-2, results obtained with the proposed algorithm were comparable to those obtained with a manual method but with the advantage of improving the precision and accuracy when quantifying small spots or faint and patchy signals.

19 May 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
BCBartomeu Mestre Cañas
Bartomeu Mestre Cañas
NTNuria Toledo-Pons
Nuria Toledo-Pons
AVAndreu Vaquer
Andreu Vaquer
STSofia Tejada
Sofia Tejada
ACAntonio Clemente
Antonio Clemente
RRRoberto De La Rica
Roberto De La Rica
Patients with chronic obstructive pulmonary disease (COPD) often experience acute exacerbations characterized by elevated neutrophilic inflammation in the lungs. Currently, this condition is diagnosed through visual inspection of sputum color and volume, a method prone to personal bias and unsuitable for patients who are unable to expectorate spontaneously. In this manuscript, we present a novel approach for measuring and monitoring exhaled myeloperoxidase (MPO), a biomarker of neutrophilic airway inflammation, without the need for sputum analysis. The method involves analyzing an unmodified surgical facemask worn by the patient for 30 min using biosensing decals that transfer antibody-coated nanoparticles. These colloids specifically interact with MPO trapped by the facemask in a dose-dependent manner, enabling the quantification of MPO levels, with a dynamic range up to 3 · 101 µg·mL−1. The proposed diagnostic approach successfully differentiated patients with acute exacerbations from stable patients with 100% sensitivity and specificity. Healthy individuals also showed significantly lower MPO levels compared to COPD patients. Our results suggest that facemask analysis could be a non-invasive diagnostic tool for airway diseases, particularly in patients unable to expectorate.

28 October 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
AVAndreu Vaquer
Andreu Vaquer
FBFrancisco Manuel Moyano Bouzada
Francisco Manuel Moyano Bouzada
STSofia Tejada
Sofia Tejada
ACAntonio Clemente
Antonio Clemente
Antonia Socias MirAntonia Socias Mir
Antonia Socias Mir
RRRoberto De La Rica
Roberto De La Rica
Microfluidic paper-based analytical devices (µPADs) are ideal for point-of-care diagnostics due to their low cost, compact size, and ease of use. However, current designs have limited multiplexing capabilities, making it difficult to simultaneously detect pathogens and biomarkers in the same sample. In this work, we introduce NanoArrayPAD−X, a novel µPAD design that combines wax-printed microfluidic networks with an array of nanoprobes for the simultaneous detection of multiple targets. This is achieved by distributing the sample through the microfluidic network containing X detection areas. There, targets are captured through physical interactions and recognized by specific antibody-coated nanoprobes released from the nanoprobe array. This generates X dots whose color depends on the concentration of the targets in the sample. A NanoArrayPAD−5 platform capable of detecting five targets was developed to aid in the diagnosis of ventilator-associated pneumonia (VAP). The sensor array could detect Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus, Escherichia coli, and the inflammatory biomarker myeloperoxidase (MPO) with a total turnaround time of 25 min, which is faster than waiting for an overnight culture and the results of an ELISA. Notably, our prototype successfully detected the targets in 87 bronchial aspirate (BAS) specimens, thus demonstrating the suitability of the platform for analyzing complex samples with sputum-like qualities. These findings establish NanoArrayPAD−X as a promising tool for the rapid, multiplexed screening of respiratory pathogens and biomarkers, with potential for guiding personalized antimicrobial therapy in suspected cases of nosocomial pneumonia.

26 June 2026 in Sensors and Actuators B: Chemical
Verified
Journal Article
Open access
DGDiego J. Gonzalo-Jiménez
Diego J. Gonzalo-Jiménez
PRPaula Rubí
Paula Rubí
AVAndreu Vaquer
Andreu Vaquer
PGPaula Gómez
Paula Gómez
SMSara Montolio
Sara Montolio
ACAntonio Clemente
Antonio Clemente